- Home
- MKDW vs ALGS Comparison
MKDW vs ALGS Comparison
Compare MKDW & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- ALGS
- Stock Information
- Founded
- MKDW 2006
- ALGS 2018
- Country
- MKDW Taiwan
- ALGS United States
- Employees
- MKDW N/A
- ALGS 70
- Industry
- MKDW
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- MKDW
- ALGS Health Care
- Exchange
- MKDW NYSE
- ALGS Nasdaq
- Market Cap
- MKDW 32.3M
- ALGS 27.9M
- IPO Year
- MKDW N/A
- ALGS 2020
- Fundamental
- Price
- MKDW $0.28
- ALGS $5.36
- Analyst Decision
- MKDW
- ALGS Strong Buy
- Analyst Count
- MKDW 0
- ALGS 1
- Target Price
- MKDW N/A
- ALGS $70.00
- AVG Volume (30 Days)
- MKDW 13.9M
- ALGS 184.5K
- Earning Date
- MKDW 12-31-2024
- ALGS 05-06-2025
- Dividend Yield
- MKDW N/A
- ALGS N/A
- EPS Growth
- MKDW N/A
- ALGS N/A
- EPS
- MKDW N/A
- ALGS N/A
- Revenue
- MKDW $3,670,722.00
- ALGS $3,945,000.00
- Revenue This Year
- MKDW N/A
- ALGS $580.86
- Revenue Next Year
- MKDW N/A
- ALGS N/A
- P/E Ratio
- MKDW N/A
- ALGS N/A
- Revenue Growth
- MKDW 16.40
- ALGS N/A
- 52 Week Low
- MKDW $0.17
- ALGS $3.76
- 52 Week High
- MKDW $16.00
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- ALGS 33.94
- Support Level
- MKDW N/A
- ALGS $4.33
- Resistance Level
- MKDW N/A
- ALGS $5.67
- Average True Range (ATR)
- MKDW 0.00
- ALGS 0.78
- MACD
- MKDW 0.00
- ALGS 0.43
- Stochastic Oscillator
- MKDW 0.00
- ALGS 49.61
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.